ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,681Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 80

$479K Total Retail Price of All Prescriptions

Rank: 7 out of 80

313 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
53% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 313 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

10% of this provider’s 313 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

1% of this provider’s 9,787 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $45 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
WARFARIN SODIUM 482 447 1 6
LISINOPRIL 463 449 2 2
SIMVASTATIN 442 411 3 3
AMLODIPINE BESYLATE 404 390 4 4
METOPROLOL TARTRATE 373 346 5 1
OMEPRAZOLE 365 317 6 24
FUROSEMIDE 340 297 7 5
ATORVASTATIN CALCIUM 332 306 8 7
LEVOTHYROXINE SODIUM 307 295 9 27
HYDROCODONE-ACETAMINOPHEN 191 154 S3 10 40
LOSARTAN POTASSIUM 162 154 11 12
ALENDRONATE SODIUM 160 160 12 71
MIRTAZAPINE 153 153 13 67
DILTIAZEM 24HR ER 151 151 14 18
TRAZODONE HCL 146 117 15 53
ATENOLOL 133 117 16 9
METOPROLOL SUCCINATE 118 113 17 8
GABAPENTIN 112 92 18 73
METFORMIN HCL 108 86 19 42
DIGOXIN 104 104 20 11
HYDROCHLOROTHIAZIDE 94 84 21 13
ADVAIR DISKUS 94 66 21 75
DIOVAN 92 90 23 19
DONEPEZIL HCL 91 91 24 68
SERTRALINE HCL 90 89 25 47
ALLOPURINOL 83 78 26 50
AZITHROMYCIN 82 69 27 72
CITALOPRAM HBR 76 65 28 61
FLUOXETINE HCL 76 49 28 105
TAMSULOSIN HCL 75 75 30 66
LISINOPRIL-HYDROCHLOROTHIAZIDE 73 70 31 38
CLOPIDOGREL 71 71 32 14
IPRATROPIUM-ALBUTEROL 70 70 33 107
CARVEDILOL 67 67 34 10
NADOLOL 66 66 35 64
PANTOPRAZOLE SODIUM 64 60 36 54
PRAVASTATIN SODIUM 63 59 37 15
LIPITOR 63 62 37 22
MELOXICAM 57 43 39 117
POLYETHYLENE GLYCOL 3350 56 56 40 81
JANUVIA 55 51 41 119
LOVASTATIN 54 47 42 31
OXYBUTYNIN CHLORIDE ER 53 53 43 123
RANITIDINE HCL 53 49 43 65
GLYBURIDE 53 53 R 43 83
ENALAPRIL MALEATE 52 50 46 29
POTASSIUM CHLORIDE 52 52 46 48
PHENYTOIN SODIUM EXTENDED 52 52 46 124
QUETIAPINE FUMARATE 51 51 49 126
ZOLPIDEM TARTRATE 51 47 49 50
CEPHALEXIN 51 51 49 126
VERAPAMIL ER 51 35 49 36
PROPRANOLOL HCL 50 50 53 70
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 17, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.